Inventor

HANAI NOBUO

JP82 patents

⚠️ This page may combine multiple inventors who share the name “HANAI NOBUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HANAI NOBUO

KYOWA HAKKO KOGYO KK

Antibody composition-producing cell

Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase

Method of modulating the activity of functional immune molecules

Cells producing antibody compositions with increased antibody dependent cytotoxic activity

Human chimeric antibody specific for the ganglioside GD3

Antibody against human interleukin-5-receptor α chain

Process for producing humanized chimera antibody

Process for producing humanized chimera antibody

Recombinant antibody and antibody fragment

Humanized antibodies to ganglioside GM2

Anti-human VEGF receptor Flt-1 monoclonal antibody

Humanized antibodies

Humanized antibodies

Method of treating cancer using a chimera antibody

Toxin conjugates

α-3 sialyltransferase

α2→3 sialyltransferase

Anti-human pulmonary carcinoma monoclonal antibody

Antibody against human insulin-like growth factor

Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain

Method of treatment by administering an antibody to human interleukin-5 receptor α chain

α-1,3-fucosyltransferase

Anti-human VEGF receptor Flt-1 monoclonal antibody

Antibody against human interleukin-5 receptor alpha chain

Humanized antibodies to ganglioside GM2

Humanized antibodies to ganglioside GM2

Anti-human VEGF receptor FLT-1 monoclonal antibody

Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3

KYOWA HAKKO KIRIN CO LTD

Antibody composition-producing cell

Methods for producing antibody compositions with increased ADCC

Method of modulating the activity of functional immune molecules to CD52

Antibody composition-producing cell in which enzyme expression is inhibited by RNAi

Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor

Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation

Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein

Method of modulating the activity of functional immune molecules

Method of modulating the activity of functional immune molecules to Her-2

Method of modulating the activity of functional immune molecules to CXCR4 protein

Method of modulating the activity of functional immune molecules

Method of modulating the activity of functional immune molecules to GM2

Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation

α-1,3-fucosyltransferase

Method for treating Th2-mediated disease

Method of modulating the activity of functional immune molecules

Antibody composition-producing cell

KANDA YUTAKA

Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase

Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation

HANAI NOBUO

Method of modulating the activity of functional immune molecules

BIOMEMBRANE INST

Naturally occurring gangliosides containing de-N-acetyl-sialic acid and their applications as modifiers of cell physiology

SHITARA KENYA

Method for producing recombinant antibody and antibody fragment thereof